PulseAI

Company profile

About PulseAI

PulseAI is a health AI company advancing cardiac diagnostics through AI-powered ECG analysis. The company's proprietary deep learning models, trained on over 15 million ECGs, deliver clinically validated performance across every ECG device form factor—from consumer smartwatches and wearable patches to clinical-grade 12-lead monitors and defibrillators. PulseAI's technology detects over 100 cardiac abnormalities including arrhythmias, myocardial infarction, and ischaemic events, providing structured diagnostic results with per-condition confidence scores. The platform integrates seamlessly with existing clinical workflows and electronic medical record systems, offering flexible deployment either on-device or in the cloud. With 28 peer-reviewed publications validating its clinical accuracy, PulseAI has demonstrated superior performance compared to traditional ECG software and native device algorithms. The company's mission addresses a critical global health challenge: cardiovascular disease claims 17.9 million lives annually, with 80% of deaths occurring in low and middle-income countries where 3.6 billion people lack access to cardiac specialists. PulseAI is closing this diagnostic gap by delivering specialist-level cardiac screening in seconds, from major hospitals to rural clinics in underserved regions. The company serves health systems, device manufacturers, life sciences companies, and research institutions worldwide.

Company description · PulseAI official website